相关实验视频

Updated: Jan 17, 2026

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

针对消化系统癌症的isoliquiritigenin:对抗瘤机制的全面审查

Zhichun Li¹, Ruohan Feng², Jinze Li³

¹Medical College, Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.

Frontiers in pharmacology

|September 22, 2025

概括

来自甘的天然化合物伊索利基基宁 (ISL) 显示出治疗消化系统癌症的前景. 它针对涉及瘤生长的多个途径,提供一种潜在有效且毒性较低的治疗选择.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
自然产品化学化学

背景情况:

消化系统癌症 (胃,结肠直肠,肝脏) 是全球癌症死亡的主要原因.
目前的化疗和免疫疗法等治疗方法存在局限性,需要新的治疗策略.
甘草中的一种黄类化合物 - - 异氧化基因素 (ISL) 具有多种药理作用,包括抗癌作用.

研究的目的:

审查在消化系统恶性瘤中Isoliquiritigenin (ISL) 的抗癌机制.
突出ISL针对各种瘤发生途径的多目标行动.
评估ISL作为消化道癌症治疗剂的潜力.

主要方法:

对Isoliquiritigenin (ISL) 和消化系统癌症的临床前研究的文献综述.
分析ISL对关键细胞过程的影响:细胞亡,自,铁亡,细胞循环和免疫调节.
综合目前对ISL分子点和瘤发生中的信号通路的理解.

主要成果:

伊索利基基因因 (ISL) 对胃癌,结肠直肠癌和肝癌模型表现出强大的抗癌活性.
ISL调节关键通路,包括亡诱导,自调节,铁亡促进,细胞循环停止和免疫反应.
ISL具有抗炎和抗氧化特性,有助于其抗癌功效.

结论:

伊索利基基因因 (ISL) 是对消化系统瘤的一种有前途的多目标治疗策略.
需要进一步的临床前和临床研究来探索ISL的全部治疗潜力.
与传统疗法相比,ISL提供了一种潜在的替代或补充治疗,其毒性较低.

关键词:

消化系统的癌症消化系统的癌症.它是独立的,它是独立的,它是独立的.甘露是一种甘.这是一个机制机制.自然化合物自然化合物

更多相关视频

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Drugs for Treatment of Diarrhea-Predominant IBS

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...